AMR & Infectious Diseases 2026
-
Why the world needs an independent evidence panel for AMR now
The world needs to tackle AMR to ensure the security of human health, our food chain, our environment and our economies. Unchecked, AMR will drive life expectancy back to medieval levels. The best way to mitigate AMR is through global governance that drives action based on evidence across the whole ‘One Health’ spectrum. We need...
-
Food chains cross borders, and so does AMR
Antibiotic stewardship in human medicine is essential, but tackling antimicrobial resistance (AMR) requires us to look beyond healthcare settings. WHO’s Global Antibiotic Resistance Surveillance Report 2025 analysed over 23 million confirmed infections from 110 countries, revealing major differences in resistance between regions and countries.1 These differences matter: effective action depends on knowing where resistance is...
-
Antibiotic resistance on the move: the role of international travel
As people cross borders, they can unknowingly carry resistant bacteria with them. Understanding this connection is essential to developing effective strategies that protect public health worldwide. Modern medicine as we know it would not be possible without effective antibiotics. Following Alexander Fleming’s discovery of penicillin in 1928 and its introduction as a treatment in the...
-
Preventing pollution can save lives, reduce the costs of antimicrobial resistance
Antimicrobial resistance (AMR) threatens our ability to treat diseases in humans, animals and plants. Drug-resistant bacterial infections are projected to cause more than 39 million deaths between 2025 and 2050.1 An obvious part of the AMR solution to save human lives remains overlooked: preventing environmental pollution. Biological and chemical pollution are significant drivers of antimicrobial...
-
Ebola shows us why vaccine preparedness cannot wait for an outbreak
The world needs to develop vaccines and tools in advance of an outbreak so that we are not scrambling in an emergency. More than 11,300 Bundibugyo ebolavirus cases have been reported in the Democratic Republic of the Congo (DRC) since May, making this the fastest-growing and second-largest Ebola outbreak on record. Nearly half of those...
-
What must change to finally deliver AMR action plans
Research and policy work are important in the fight against antimicrobial resistance (AMR), but we won’t succeed until we move from dialogue to delivery. In the decade since the first UN High-Level Meeting on AMR, research has advanced, and policy commitments have strengthened. Yet, a major challenge remains: turning those commitments into meaningful, sustained action....
-
AMR and emerging infections: a One Health challenge
Antimicrobial resistance (AMR) and emerging infections share key drivers. A One Health approach is essential to connect human, animal and environmental health and tackle both threats. The next infectious disease crisis may not fit neatly into a single category, and neither should our response. Antimicrobial resistance (AMR) and emerging infectious diseases (EIDs) are often addressed...
-
Disability equity is missing from the fight against antimicrobial resistance
People with disabilities frequently face barriers to healthcare; vaccination; water, sanitation and hygiene (WASH); transportation; and accessible health information. These barriers are often created or intensified by inaccessible infrastructure, poverty, stigma and ableism. Antimicrobial resistance (AMR) is often framed as a problem caused exclusively by antibiotic overuse and misuse. However, conditions that determine who can...
-
NTD elimination is an investment in our shared future
Neglected tropical diseases (NTDs) are 21 preventable and treatable diseases affecting more than 1 billion people, primarily in communities facing poverty and limited access to essential services.1 Investing in eliminating NTDs offers something rare: the opportunity to defeat a group of diseases while delivering returns far beyond health. Extraordinary progress at risk Despite this enormous...
-
Getting antibiotic R&D incentives right, from political commitment to impact
Antimicrobial resistance represents one of the most pressing threats to global health, jeopardising many of the advances in medical care that depend on the availability of effective antibiotics. Most concerningly, the pipeline for new antibiotics is projected to decline further without proper action. At its core, this issue is economic: antibiotics require significant investment to...
Global Cause